Artrya (ASX:AYA) Gross Margin %: 0.00% (As of Dec. 2025)


ASX:AYA Artrya Ltd ASX:AYA
30 GF Score
Price A$5.21
! 1 Warning Sign
View Full Analysis

What is Artrya Gross Margin %?

Artrya ASX:AYA -1.33% 30 Gross Margin % is 0.00% as of Dec. 2025. GuruFocus rates ASX:AYA with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 629 Healthcare Providers & Services companies, Artrya ranks worse than 158982.35% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Artrya's Gross Profit for the six months ended in Dec. 2025 was A$0.07 Mil. Artrya's Revenue for the six months ended in Dec. 2025 was A$0.07 Mil. Therefore, Artrya's Gross Margin % for the quarter that ended in Dec. 2025 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for Artrya's Gross Margin % or its related term are showing as below:


ASX:AYA's Gross Margin % is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 40.09
* Ranked among companies with meaningful Gross Margin % only.

Artrya had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Artrya was 0.00% per year.


Artrya  (ASX:AYA) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Artrya had a gross margin of N/A% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Artrya Gross Margin % Related Terms


Artrya Gross Margin % Historical Data

* Premium members only.

The historical data trend for Artrya's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artrya Gross Margin % Chart

Artrya Annual Data
Trend Jun21 Jun22 Jun23 Jun24 Jun25
Gross Margin %
0.00 0.00 0.00 0.00 0.00

Artrya Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ASX:AYA vs VEEV, BTSG, TEM: Gross Margin % Comparison

For the Health Information Services subindustry, Artrya's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Artrya Gross Margin % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Artrya's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Artrya's Gross Margin % falls into.


ASX:AYA
30GF Score
Artrya Ltd ASX:AYA
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Artrya Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Artrya's Gross Margin for the fiscal year that ended in Jun. 2025 is calculated as

Gross Margin % (A: Jun. 2025 )=Gross Profit (A: Jun. 2025 ) / Revenue (A: Jun. 2025 )
=0 / 0.028
=(Revenue - Cost of Goods Sold) / Revenue
=(0.028 - 0) / 0.028
=N/A %

Artrya's Gross Margin for the quarter that ended in Dec. 2025 is calculated as


Gross Margin % (Q: Dec. 2025 )=Gross Profit (Q: Dec. 2025 ) / Revenue (Q: Dec. 2025 )
=0.1 / 0.068
=(Revenue - Cost of Goods Sold) / Revenue
=(0.068 - 0) / 0.068
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 0.00% mean?
Artrya (ASX:AYA) has a Gross Margin % of 0.00% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Artrya and its competitors. According to the industry distribution chart, Artrya ranks #999999 out of 629 companies in the Healthcare Providers & Services industry.
Is Artrya's Gross Margin % too high?
Artrya's current Gross Margin % is 0.00%. Based on the distribution chart, Artrya ranks #999999 out of 629 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Artrya has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Artrya's Gross Margin % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Artrya ranks #999999 out of 629 companies for Gross Margin %. This places Artrya in the lower half of its industry. The industry median Gross Margin % is 40.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 629 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Artrya and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Artrya's current Gross Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Artrya stock overvalued right now?
Artrya (ASX:AYA) has a current Gross Margin % of 0.00%. The current Gross Margin % is 0.00%. Artrya's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Artrya (ASX:AYA), the current Gross Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Artrya Business Description

Address 1257 Hay Street, West Perth, Perth, WA, AUS, 6005
Artrya Ltd is a medical technology company. The company is engaged in the development and commercialization of Artrya Salix, its patented artificial intelligence platform that detects, diagnoses, and helps address coronary artery disease. It is managed based on a single segment, being the development of AI-driven CCTA image analysis technology.
30GF Score

Get the complete analysis for ASX:AYA

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$5.21
Price